SCHEMBL3266299

SCHEMBL3266299

CNc1ccccc1Nc1nc2ccccc2s1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 15/20 0.71
RAB9A P51151 15/20 0.71
SMN1; SMN2 Q16637 14/20 0.71
LMNA P02545 5/20 0.66
NFKB1 P19838 4/20 0.66
NFKB2 Q00653 4/20 0.66
RELA Q04206 4/20 0.66
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
MAPT P10636 4/20 0.60
CASP3 P42574 1/20 0.60
SENP8 Q96LD8 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
SENP6 Q9GZR1 1/20 0.60
IDO1 P14902 1/20 0.54
POLB P06746 1/20 0.54
PKM P14618 1/20 0.52
ADORA1 P30542 1/20 0.51
DYRK1A Q13627 1/20 0.51
ALDH1A1 P00352 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3278505 0.91 NPC1 (0.77) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL1819335 0.83 NPC1 (1.00) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL29909885 0.82 IDO1 (0.66) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL758888 0.82 IDO1 (0.66) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL30073965 0.82 NPC1 (0.78) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL3112891 0.82 NPC1 (0.78) NPC1RAB9ASMN1; SMN2LMNANFKB1
Hydrochloric Acid SCHEMBL3130678 0.80 IDO1 (0.63) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL1856861 0.80 NPC1 (0.67) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL2461208 0.80 NPC1 (0.67) NPC1RAB9ASMN1; SMN2LMNANFKB1
SCHEMBL1818561 0.80 NPC1 (0.73) NPC1RAB9ASMN1; SMN2LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9074128-B2 Metal complexes having azaborol ligands and electronic device having the same MERCK PATENT GMBH (DE) 2015-07-07 US disclosed
US-8722898-B2 2014-05-13 US disclosed
US-20120004407-A1 METAL COMPLEXES HAVING AZABOROL LIGANDS AND ELECTRONIC DEVICE HAVING THE SAME MERCK PATENT GMBH (DE) 2012-01-05 US disclosed
WO-2010099852-A1 METAL COMPLEXES HAVING AZABOROL LIGANDS AND ELECTRONIC DEVICE HAVING THE SAME MERCK PATENT GMBH (DE) 2010-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004407-A1 METAL COMPLEXES HAVING AZABOROL LIGANDS AND ELECTRONIC DEVICE HAVING THE SAME ICOSLG, ERAL1, CTCF NPC1 3946/4885RAB9A 2083/4885SMN1; SMN2 4643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.